The ten drugs and pharma companies impacted are:
Eliquis - Bristol-Myers Squibb (BMY), Pfizer (PFE)
Jardiance - Boehringer Ingelheim, Eli Lilly (LLY)
Xarelto- Bayer (BAYRY), Johnson & Johnson (JNJ)
Januvia - Merck (MRK)
Farxiga - AstraZeneca (AZN)
Entresto - Novartis (NVS)
Enbrel - Amgen (AMGN)
Imbruvica - Johnson & Johnson (JNJ), AbbVie (ABBV)
Stelara - Johnson & Johnson (JNJ)
Fiasp, NovoLog - Novo Nordisk (NVO)
